Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo
Rajamani, Bharathi M, Illangeswaran, Raveen Stephen Stallon, Benjamin, Esther Sathya Bama, Balakrishnan, Balaji, Jebanesan, Daniel Zechariah Paul, Das, Saswati, Pai, Aswin Anand, Vidhyadharan, Rakhi Thalayattu, Mohan, Ajith, Karathedath, Sreeja, Abraham, Aby, Mathews, Vikram, Velayudhan, Shaji R, Balasubramanian, Poonkuzhali
Published in Frontiers in pharmacology (2023)
Published in Frontiers in pharmacology (2023)
Get full text
Journal Article
Chemotherapeutic drugs elicit stemness and metabolic alteration to mediate acquired drug-resistant phenotype in acute myeloid leukemia cell lines
Illangeswaran, Raveen Stephen Stallon, Jebanesan, Daniel Zechariah Paul, Sivakumar, Kezia Kanimozhi, Vidhyadharan, Rakhi Thalayattu, Rajamani, Bharathi M., Janet, Nancy Beryl, David, Ernest, Velayudhan, Shaji Ramachandran, Mathews, Vikram, Balasubramanian, Poonkuzhali
Published in Leukemia research (01.05.2023)
Published in Leukemia research (01.05.2023)
Get full text
Journal Article
Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia
Jebanesan, Daniel Zechariah Paul, Illangeswaran, Raveen Stephen Stallon, Rajamani, Bharathi M., Vidhyadharan, Rakhi Thalayattu, Das, Saswati, Bijukumar, Nayanthara K., Balakrishnan, Balaji, Mathews, Vikram, Velayudhan, Shaji R., Balasubramanian, Poonkuzhali
Published in Annals of hematology (01.06.2024)
Published in Annals of hematology (01.06.2024)
Get full text
Journal Article
Immortalised chronic myeloid leukemia (CML) derived mesenchymal stromal cells (MSCs) line retains the immunomodulatory and chemoprotective properties of CML patient-derived MSCs
Benjamin, Esther Sathya Bama, Vinod, Elizabeth, Illangeswaran, Raveen Stephen Stallon, Rajamani, Bharathi M., Vidhyadharan, Rakhi Thalayattu, Bagchi, Abhirup, Maity, Arnab, Mohan, Ajith, Parasuraman, Ganesh, Amirtham, Soosai Manickam, Abraham, Aby, Velayudhan, Shaji R, Balasubramanian, Poonkuzhali
Published in Cellular signalling (01.04.2024)
Published in Cellular signalling (01.04.2024)
Get full text
Journal Article
Corrigendum to “Chemotherapeutic drugs elicit stemness and metabolic alteration to mediate acquired drug-resistant phenotype in acute myeloid leukemia cell lines” [Leukemia Res. 128, 107054]
Illangeswaran, Raveen Stephen Stallon, Jebanesan, Daniel Zechariah Paul, Sivakumar, Kezia Kanimozhi, Vidhyadharan, Rakhi Thalayattu, Rajamani, Bharathi M., Janet, Nancy Beryl, David, Ernest, Velayudhan, Shaji Ramachandran, Mathews, Vikram, Balasubramanian, Poonkuzhali
Published in Leukemia research (01.07.2023)
Published in Leukemia research (01.07.2023)
Get full text
Journal Article
Abstract 3973: Transcriptomic profiling of in-vitro modelled drug resistant AML cell lines unravel metabolic and stemness gene signatures
Illangeswaran, Raveen Stephen, Jebanesan, Daniel Zechariah, Sivakumar, Kezia Kanimozhi, Vidhyadharan, Rakhi Thalayattu, Mathews, Vikram, Velayudhan, Shaji Ramachandran, Balasubramanian, Poonkuzhali
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
Abstract 3977: Pharmacological inhibition of Nrf2 overcomes acquired resistance to arsenic trioxide in FLT3 mutated acute myeloid leukemia
Jebanesan, Daniel Zechariah, Illangeswaran, Raveen Stephen, Das, Saswati, Vidhyadharan, Rakhi Thalayattu, Bijukumar, Nayanthara Karpillymoola, Rajamani, Bharathi M., Balakrishnan, Balaji, Mathews, Vikram, Velayudhan, Shaji Ramachandran, Balasubramanian, Poonkuzhali
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article